Table 4_Antifungal mechanism and transcriptome analysis of Bacillomycin D-C16 against Fusarium oxysporum.xlsx

Background<p>Fusarium oxysporum is a globally distributed soil-borne pathogen that causes substantial economic losses in cash crops. Bacillomycin D-C16, a natural antimicrobial lipopeptide produced by Bacillus subtilis, exhibited potent fungicidal activity against F. oxysporum, with a minimum...

Cur síos iomlán

Sábháilte in:
Sonraí bibleagrafaíochta
Príomhchruthaitheoir: Fuxing Lin (7418234) (author)
Rannpháirtithe: Yang Jiao (147576) (author), Hua Jiang (123031) (author), Yu Zheng (2950) (author), Shiqin Wu (22681616) (author), Li Zhou (54356) (author), Xiangmei Ren (2110447) (author), Zhaoxin Lu (701734) (author), Yuanhong Li (2414860) (author)
Foilsithe / Cruthaithe: 2025
Ábhair:
Clibeanna: Cuir clib leis
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!
_version_ 1849927634709905408
author Fuxing Lin (7418234)
author2 Yang Jiao (147576)
Hua Jiang (123031)
Yu Zheng (2950)
Shiqin Wu (22681616)
Li Zhou (54356)
Xiangmei Ren (2110447)
Zhaoxin Lu (701734)
Yuanhong Li (2414860)
author2_role author
author
author
author
author
author
author
author
author_facet Fuxing Lin (7418234)
Yang Jiao (147576)
Hua Jiang (123031)
Yu Zheng (2950)
Shiqin Wu (22681616)
Li Zhou (54356)
Xiangmei Ren (2110447)
Zhaoxin Lu (701734)
Yuanhong Li (2414860)
author_role author
dc.creator.none.fl_str_mv Fuxing Lin (7418234)
Yang Jiao (147576)
Hua Jiang (123031)
Yu Zheng (2950)
Shiqin Wu (22681616)
Li Zhou (54356)
Xiangmei Ren (2110447)
Zhaoxin Lu (701734)
Yuanhong Li (2414860)
dc.date.none.fl_str_mv 2025-11-25T12:12:40Z
dc.identifier.none.fl_str_mv 10.3389/fmicb.2025.1698200.s007
dc.relation.none.fl_str_mv https://figshare.com/articles/dataset/Table_4_Antifungal_mechanism_and_transcriptome_analysis_of_Bacillomycin_D-C16_against_Fusarium_oxysporum_xlsx/30705482
dc.rights.none.fl_str_mv CC BY 4.0
info:eu-repo/semantics/openAccess
dc.subject.none.fl_str_mv Microbiology
Bacillomycin D-C16
Fusarium oxysporum
transcriptome
mitochondrial dysfunction
ROS accumulation
DNA binding
dc.title.none.fl_str_mv Table 4_Antifungal mechanism and transcriptome analysis of Bacillomycin D-C16 against Fusarium oxysporum.xlsx
dc.type.none.fl_str_mv Dataset
info:eu-repo/semantics/publishedVersion
dataset
description Background<p>Fusarium oxysporum is a globally distributed soil-borne pathogen that causes substantial economic losses in cash crops. Bacillomycin D-C16, a natural antimicrobial lipopeptide produced by Bacillus subtilis, exhibited potent fungicidal activity against F. oxysporum, with a minimum inhibitory concentration (MIC) of 8 mg/L. However, the precise mechanism of its action against F. oxysporum remains uncharacterized.</p>Methods<p>In this study, we employed transmission electron microscopy (TEM) to analyze morphological and ultrastructural alterations in F. oxysporum treated with Bacillomycin D-C16 and RNA-seq profiling combined with biochemical assays to elucidate Bacillomycin D-C16's mode of action against F. oxysporum.</p>Results<p>TEM revealed that Bacillomycin D-C16 induced structural disruption of mitochondria in F. oxysporum. Transcriptome analysis identified 3,370 differentially expressed genes (DEGs) in F. oxysporum, comprising 1,488 up-regulated and 1,882 down-regulated genes. Cluster analysis revealed significant changes in gene expression patterns: DEGs associated with mitochondrial function [including oxidative phosphorylation and citrate cycle (TCA cycle) pathways] were down-regulated, while most DEGs involved in glutathione metabolism were up-regulated. Furthermore, nearly all DEGs related to DNA replication were significantly suppressed. Biochemical assays confirmed these observations: Reduced activities of mitochondrial enzymes [malate dehydrogenase (MDH), isocitrate dehydrogenase (IDH), pyruvate dehydrogenase (PDH), and complexes I–V], decreased mitochondrial membrane potential, and diminished ATP content collectively indicated mitochondrial dysfunction. Depleted glutathione (GSH) levels accompanied by elevated glutathione s-transferase (GST) activity, increased malondialdehyde (MDA) content, and accumulated reactive oxygen species (ROS) confirmed disruptions in glutathione metabolism and oxidative stress. Ultraviolet (UV) absorption spectra, fluorescence spectroscopy, and molecular docking simulations demonstrated Bacillomycin D-C16′s preferential binding to the major groove of DNA, leading to abnormal DNA replication.</p>Conclusions<p>These findings collectively demonstrate that Bacillomycin D-C16 inhibits F. oxysporum growth through multifaceted mechanisms involving transcriptional regulation, mitochondrial impairment, ROS accumulation, and interference with DNA replication.</p>
eu_rights_str_mv openAccess
id Manara_10c69b3f7ea32e40bee425144f75ecb9
identifier_str_mv 10.3389/fmicb.2025.1698200.s007
network_acronym_str Manara
network_name_str ManaraRepo
oai_identifier_str oai:figshare.com:article/30705482
publishDate 2025
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
rights_invalid_str_mv CC BY 4.0
spelling Table 4_Antifungal mechanism and transcriptome analysis of Bacillomycin D-C16 against Fusarium oxysporum.xlsxFuxing Lin (7418234)Yang Jiao (147576)Hua Jiang (123031)Yu Zheng (2950)Shiqin Wu (22681616)Li Zhou (54356)Xiangmei Ren (2110447)Zhaoxin Lu (701734)Yuanhong Li (2414860)MicrobiologyBacillomycin D-C16Fusarium oxysporumtranscriptomemitochondrial dysfunctionROS accumulationDNA bindingBackground<p>Fusarium oxysporum is a globally distributed soil-borne pathogen that causes substantial economic losses in cash crops. Bacillomycin D-C16, a natural antimicrobial lipopeptide produced by Bacillus subtilis, exhibited potent fungicidal activity against F. oxysporum, with a minimum inhibitory concentration (MIC) of 8 mg/L. However, the precise mechanism of its action against F. oxysporum remains uncharacterized.</p>Methods<p>In this study, we employed transmission electron microscopy (TEM) to analyze morphological and ultrastructural alterations in F. oxysporum treated with Bacillomycin D-C16 and RNA-seq profiling combined with biochemical assays to elucidate Bacillomycin D-C16's mode of action against F. oxysporum.</p>Results<p>TEM revealed that Bacillomycin D-C16 induced structural disruption of mitochondria in F. oxysporum. Transcriptome analysis identified 3,370 differentially expressed genes (DEGs) in F. oxysporum, comprising 1,488 up-regulated and 1,882 down-regulated genes. Cluster analysis revealed significant changes in gene expression patterns: DEGs associated with mitochondrial function [including oxidative phosphorylation and citrate cycle (TCA cycle) pathways] were down-regulated, while most DEGs involved in glutathione metabolism were up-regulated. Furthermore, nearly all DEGs related to DNA replication were significantly suppressed. Biochemical assays confirmed these observations: Reduced activities of mitochondrial enzymes [malate dehydrogenase (MDH), isocitrate dehydrogenase (IDH), pyruvate dehydrogenase (PDH), and complexes I–V], decreased mitochondrial membrane potential, and diminished ATP content collectively indicated mitochondrial dysfunction. Depleted glutathione (GSH) levels accompanied by elevated glutathione s-transferase (GST) activity, increased malondialdehyde (MDA) content, and accumulated reactive oxygen species (ROS) confirmed disruptions in glutathione metabolism and oxidative stress. Ultraviolet (UV) absorption spectra, fluorescence spectroscopy, and molecular docking simulations demonstrated Bacillomycin D-C16′s preferential binding to the major groove of DNA, leading to abnormal DNA replication.</p>Conclusions<p>These findings collectively demonstrate that Bacillomycin D-C16 inhibits F. oxysporum growth through multifaceted mechanisms involving transcriptional regulation, mitochondrial impairment, ROS accumulation, and interference with DNA replication.</p>2025-11-25T12:12:40ZDatasetinfo:eu-repo/semantics/publishedVersiondataset10.3389/fmicb.2025.1698200.s007https://figshare.com/articles/dataset/Table_4_Antifungal_mechanism_and_transcriptome_analysis_of_Bacillomycin_D-C16_against_Fusarium_oxysporum_xlsx/30705482CC BY 4.0info:eu-repo/semantics/openAccessoai:figshare.com:article/307054822025-11-25T12:12:40Z
spellingShingle Table 4_Antifungal mechanism and transcriptome analysis of Bacillomycin D-C16 against Fusarium oxysporum.xlsx
Fuxing Lin (7418234)
Microbiology
Bacillomycin D-C16
Fusarium oxysporum
transcriptome
mitochondrial dysfunction
ROS accumulation
DNA binding
status_str publishedVersion
title Table 4_Antifungal mechanism and transcriptome analysis of Bacillomycin D-C16 against Fusarium oxysporum.xlsx
title_full Table 4_Antifungal mechanism and transcriptome analysis of Bacillomycin D-C16 against Fusarium oxysporum.xlsx
title_fullStr Table 4_Antifungal mechanism and transcriptome analysis of Bacillomycin D-C16 against Fusarium oxysporum.xlsx
title_full_unstemmed Table 4_Antifungal mechanism and transcriptome analysis of Bacillomycin D-C16 against Fusarium oxysporum.xlsx
title_short Table 4_Antifungal mechanism and transcriptome analysis of Bacillomycin D-C16 against Fusarium oxysporum.xlsx
title_sort Table 4_Antifungal mechanism and transcriptome analysis of Bacillomycin D-C16 against Fusarium oxysporum.xlsx
topic Microbiology
Bacillomycin D-C16
Fusarium oxysporum
transcriptome
mitochondrial dysfunction
ROS accumulation
DNA binding